期刊文献+

多重耐药铜绿假单胞菌的耐药性分析 被引量:41

Analysis of antimicrobial resistance of multidrug resistant Pseudomonas aeruginosa
在线阅读 下载PDF
导出
摘要 目的分析2007年—2009年我院铜绿假单胞菌多重耐药(multidrug resistant,MDR)菌株对多种抗菌药物的耐药性变迁。方法收集2007年1月—2009年12月我院细菌室分离的铜绿假单胞菌,采用琼脂扩散法作敏感试验。结果 3年来共分离铜绿假单胞菌422株,其中MDR菌株100株,占23.70%。分离出的MDR菌株分布在呼吸科普通病房(13.00%)、呼吸重症监护病房(RICU)(29.00%)、外科病房(9.00%)、外科监护病房(SICU)(20.00%)、急诊科(5.00%)和其他内科病房(14.00%)。各科室中,分离出的MDR菌株数占所有标本分离的该菌株数的比例最高的是RICU(42.39%,39/92),其次为SICU(37.04%,20/54)。痰标本分离的MDR菌株占76.00%(76/100),其次为尿液(5.00%,5/100)。铜绿假单胞菌MDR菌株的分离率在3年期间无显著性差异。3年期间铜绿假单胞菌MDR菌株对头孢哌酮/舒巴坦耐药率最低(分别为25.00%、37.93%、40.48%);对所有检测的抗菌药物耐药率各年间无显著性差异。RICU与SICU分离的MDR菌株对亚胺培南、美罗培南耐药率显著高于其他普通病房,对其余检测的抗菌药物耐药率与其他病房无显著性差异。结论我院铜绿假单胞菌MDR菌株的耐药情况近年来十分严峻,在RICU与SICU,MDR菌株对碳青霉烯类耐药尤其严重,因此需严密监测细菌耐药性,指导合理使用抗菌药物。 Objective To analyze the changing pattern of antimicrobial resistance of multidrug resistant (MDR) Pseudomonas aeruginosa during 2007-2009. Methods Strains of P. aeruginosa isolates from January 2007 to December 2009 were collected. Antimicrobial susceptibility of clinical isolates was tested by Kirby-Bauer method. Results A total of 422 P aeruginosa were collected during 3 years, among which 100 isolates were MDR strains (23.70%). Of the MDR strains, 13 strains (13.00 %) were from respiratory unit, 29 strains (29.00%) from respiratory intensive care unit (RICU), 9 strains (9.00 %) from surgical units, 20 strains (20.00%) from surgical intensive care unit (SICU), 5 strains (5.00 %) from emergency units, 14 strains (14.00%) from other medical units. Among all units, the percentage of the MDR stains to whole P aeruginosa stains collected was the highest in RICU (42.39%, 39/92 ), then SICU (37.04%, 20/54 ). Most strains (76.00%) were isolated from sputum, then urine (5.00%, 5/100). The prevalences of MDR P. aeruginosa during the three years were similar. From 2007 to 2009, the resistance rates of MDR P. aeruginosa to cefoperazone / sulbactam were the lowest (25.00%, 37.93% and 40.48%, respectively); the resistance rates to all tested antimicrobial agents had no significant differences during theses years. The resistance rates of MDR strains isolated from RICU and SICU to imipenem, meropenem were much more higher than those of strains isolated from other units, while which to other antimicrobial agents were similar to those from other units. Conclusions The condition of antimicrobial resistance of MDR P. aeruginosa was quite severe in our hospital in recent years, especially the resistance rates of MDR strains isolated from RICU and surgical ICU to carbapenems were much more higher than other units, so antimicrobial resistance surveillance should be strengthened to direct rational use of antibiotics.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2012年第1期63-67,共5页 Chinese Journal of Antibiotics
关键词 铜绿假单胞菌 多重耐药 耐药性 抗菌药物 Pseudomonas aeruginosa Multidrug resistant strains Antimicrobial resistance Antimicrobial agents
  • 相关文献

参考文献11

  • 1Walkty A, DeCorby M, Nichol K, et al, Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study[J]. Diagn Microbiol Infect Dis, 2008, 61:217-221.
  • 2Zavascki A P, Carvalhaes resistant Pseudomonas C G, Picao R C, et al. Multidrugaeruginosa and Acinetobacter baumannii: Resistance mechanisms and implications for therapy[J]. Expert Rev Anti Infect Ther, 2010,8(1):71-93.
  • 3Paterson D L. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis, 2006, 43:S43-S48.
  • 4Suairez C, Pefia C, Tubau F, et al. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections[J]. Jlnfect, 2009, 58:285-290.
  • 5Wang H, Chen M J, Ni Y X, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008[J]. lnt JAntimicrob Agents, 2010, 35: 227-234.
  • 6Hirsch E B, Tam V H. Pseudomonas aeruginosa infection on patient outcomes[J]. Expert Rev Pharmacoeeonom Outcomes Res, 2010, 10(4): 441-451.
  • 7Aloush V, Venezia S N, Igra Y S, et al. Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact[J]. Antimicrob Agents Chemother, 2006, 50(1): 43-48.
  • 8Cardoso O, Alves A F, Leitao R. Surveillance of antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates from a central hospital in Portuga[J]. J Antimicrob Agents, 2007, 60(2): 452-454.
  • 9Pakyz A L, Oinonen M, Polk R E, et al. Relationship of carbapenem restriction in 22 university teaching hospital to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 2009, 53(5): 1983-1986.
  • 10Kaleem F, Usman J, Hassan A, et al. Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan[J]. Jlnfect Dev Ctries, 2010, 4(12): 810-813.

二级参考文献34

  • 1王卫萍,邵海枫,韩丽丽,王锦娜,史利宁,张小卫.铜绿假单胞菌对亚胺培南耐药机制的研究[J].医学研究生学报,2006,19(11):970-972. 被引量:10
  • 2Abraham EP,Chain E.National Nosocomial Infections Surveillance (NNIS) System Report,data summary from January 1992 through June 2003,issued August 2003[J].Am J Infect Control,2003,31 (8):481-498.
  • 3Abraham EP,Chain E.An enzyme from bacteria able to destroy penicillin 1940[J].Rev Infect Dis,1988,10(4):677-678.
  • 4Stover CK,Pham XQ,Erwin AL,et al.Complete genome sequence of Pseudomonas aeryginosa PA01,an opportunistic pathogen[J].Nature,2000,406(6799):959-964.
  • 5Lambert PA.Mechanisms of antibiotic resistance in Pssudomonas aernginosa[J].J R Soc Med,2002,95(Suppl 41):22-26.
  • 6Hatch RA,Schiller NL Alginate lyase promotes diffusion of aminoglycesides through the extracellular polysaccharide of muceid Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,1998,42(4):974-977.
  • 7Ciofu O,Fussing V,Bagge N,et al.Characterization of paired mucoid/non-mucoid Pseudomonas aeruginesa isolates from Danish cystic fibrosis patients:antibiotic resistance,b-lactamass activity and Riboprinting[J].J Antimicrob Chemother,2001,48 (3):391-396.
  • 8Ernst RK,Yi EC,Guo L,et al.Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Psoudomonas aeruginosa[J].Science,1999,286(5444):1561-1565.
  • 9Farm A,Islam S,Stralfors A,et al.Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Psoudomones aeruginosa to imipenem and meropenem[J].Int J Antimicrob Agents,2008,31 (5):427-433.
  • 10Giske CG,Buarφ L,Sundsfjord A,et al.Alterations of porin,pumps,and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeroginosa[J].Microb Drug Resist,2008,14(1):23-30.

共引文献20

同被引文献327

引证文献41

二级引证文献188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部